-
Trump Signs HALT Fentanyl Act With Research Provisions
On July 16, 2025, President Donald Trump signed the Halt All Lethal Trafficking (HALT) Fentanyl Act, primarily aimed at permanently banning fentanyl analogues. However, the…
-
What’s Happening with Federal Rescheduling of Cannabis?
Background & Timeline The Trump Administration and Rescheduling Leadership & Policy Signals Legislative Roadblocks What Would Rescheduling Actually Mean? If finalized, moving cannabis to Schedule III,…
-
National Context: Medical vs. Recreational Cannabis Laws
Medical Cannabis Protocols: State-by-State Possession & Timing Below are selected states’ medical allowance versus recreational limits, highlighting purchase/possession caps and patient-specific timelines. California Colorado Massachusetts…
-
Psilocybin Legalization in U.S. States
As of mid‑2025, three U.S. states have legalized medical use of psilocybin, though federal law still classifies psilocybin as Schedule I: Oregon Colorado New Mexico Local…
-
Are Roadside Cannabis Tests Scientifically Valid?
New Analyses Label Cannabis Roadside Tests “Pseudoscience” A June 2025 perspective in the Journal of Studies on Alcohol and Drugs concluded that many methods police use…
-
Cannabis and Federal Firearms Law: The Basics
Under federal law, marijuana remains a Schedule I controlled substance, making its use illegal at the federal level—even when state law permits medical or recreational use.…
-
Cannabis & Synthetic THC: What’s Happening in Today’s Market?
Cannabis products today are broadly categorized into plant-derived THC, hemp‑derived cannabinoids, and less commonly, synthetic THC, which includes pharmaceutical formulations and unregulated designer compounds. The…
-
Trump Administration’s DEA Nominee: Terrance (Terry) Cole
President Trump’s second nominee for DEA Administrator is Terrance Cole, a former DEA veteran with over 20 years of service who most recently served as Virginia’s…
